Take it as soon as you remember as long as it is within 5 days
Some individuals may also experience headaches or fatigue
Semaglutide and tirzepatide employ fixed-dose escalation regardless of body weight, while some research peptides adjust doses to body mass
Over a period of 4 to 8 weeks, as you move from the initial titration doses to higher therapeutic levels, the decrease in hunger becomes a steady state rather than a fluctuating feeling
Summary Microdosing is typically treated as a tolerability-first, clinician-guided approach, involving starts below the usual 2.5 mg step, extending escalation windows from 4 to 8 weeks or more, or pausing at intermediate maintenance doses, such as 5 mg or 7.5 mg, to prioritize steady adherence and symptom control